Paul Nguewa

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Roque Díaz, Paul Nguewa, Ricardo Parrondo et al. · BMC Cancer · 2010 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) – Pluronic® F127 copolymers for controlled protein release

Esther Moreno, Juana Schwartz, Eneko Larrañeta et al. · International Journal of Pharmaceutics · 2013 · 79 citations

Natural Sciences, Biomedical Engineering, Materials Engineering +17

Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents

Ylenia Baquedano, Verónica Alcolea, Miguel Toro-Londoño et al. · Antimicrobial Agents and Chemotherapy · 2016 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

Leyre Larzábal, Paul Nguewa, D Blanco et al. · British Journal of Cancer · 2011 · 68 citations · Full text

Medicine, Molecular Biology, Oncology +15

Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases

José Peña‐Guerrero, Paul Nguewa, Alfonso T. García‐Sosa · Wiley Interdisciplinary Reviews Computational Molecular Science · 2021 · 67 citations

Pharmacy, Chemical Biology, Medicinal Chemistry +14